Department of Emergency Medicine

Convalescent plasma improved survival in COVID-19 patients with blood cancers

Treatment with convalescent plasma vastly improved the survival rate of patients hospitalized for COVID-19 who also had hematologic malignances that compromise the immune system, according to new data released by the COVID-19 and Cancer Consortium (CCC19).

Heart failure study seeks to reduce hospitalizations

A national study led by researchers at Vanderbilt University Medical Center has found that many patients who arrive at the emergency department (ED) with acute heart failure can be safely discharged with self-care guidance and frequent phone appointments, avoiding the need for hospitalization.

Hydroxychloroquine does not help patients hospitalized with COVID-19: Study

Findings from a national study published Nov. 9 in the Journal of the American Medical Association (JAMA) “do not support” the use of hydroxychloroquine for the treatment of adult patients hospitalized with COVID-19, the report concludes.

Self named VP for Clinical Research Networks and Strategy

Wesley Self, MD, MPH, has been appointed Vice President for Clinical Research Networks and Strategy at Vanderbilt University Medical Center.

Clinical trial to test HIV drugs to treat COVID-19

Vanderbilt University Medical Center, in collaboration with the University of Colorado and Beth Israel Deaconess Medical Center in Boston, is leading one of the first “telemedicine” clinical trials to test a potential treatment for COVID-19.

Emergency medical staff practice pediatric life support techniques at Georgetown Public Hospital in Georgetown, Guyana. (photo taken prior to social distancing)

Nurse-led training program in Guyana carries on

Just weeks before the COVID-19 pandemic suspended international travel, Vanderbilt University Medical Center nurses completed two new educational initiatives in the South American country of Guyana, and a strong collaboration continues virtually in response to the coronavirus.

1 4 5 6 7 8 12